Evidence map›Paper›PMID 35128604›Full record

ArticleActa neurochirurgica2022

Medicosurgical management of deep wound infections after thoracolumbar instrumentation: risk factors of poor outcomes.

Paul Frechon, Jocelyn Michon, Aurelie Baldolli, Evelyne Emery, François Lucas, Renaud Verdon, Anna Fournier, Thomas Gaberel

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Paul FrechonDepartment of Neurosurgery, Caen University Hospital, Avenue de La Côte de Nacre, CHU Caen, 14033, Caen, France. paul.frechon@neurochirurgie.fr.ORCID http://orcid.org/0000-0003-4424-7016
Jocelyn MichonDepartment of Infectious Diseases, Caen University Hospital, Avenue de La Côte de Nacre, CHU Caen, 14033, Caen, France.
Aurelie BaldolliDepartment of Infectious Diseases, Caen University Hospital, Avenue de La Côte de Nacre, CHU Caen, 14033, Caen, France.
Evelyne EmeryDepartment of Neurosurgery, Caen University Hospital, Avenue de La Côte de Nacre, CHU Caen, 14033, Caen, France.
François LucasDepartment of Neurosurgery, Saint Martin Private Hospital, 18 rue des Roquemonts, 14000, Caen, France.
Renaud VerdonDepartment of Infectious Diseases, Caen University Hospital, Avenue de La Côte de Nacre, CHU Caen, 14033, Caen, France.
Anna FournierDepartment of Infectious Diseases, Caen University Hospital, Avenue de La Côte de Nacre, CHU Caen, 14033, Caen, France.
Thomas GaberelDepartment of Neurosurgery, Caen University Hospital, Avenue de La Côte de Nacre, CHU Caen, 14033, Caen, France.
Centre Hospitalier Universitaire de Caen Normandie · FRInserm · FRLaboratoire Saint Martin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical site infection (SSI) after thoracolumbar osteosynthesis is a common complication. Its management relies on surgical revision and antibiotic therapy, but treatment failure is not uncommon. The aim of our study was to assess the frequency of SSI management failure and its risk factors.

methodsA retrospective study of patients hospitalized from 2011 to 2019 at the University Hospital of Caen was carried out. The infection rate and the time to onset of failure were assessed over a minimum follow-up of 1 year. Treatment failure was defined as the occurrence of a new intervention in the spine in the year following the end of antibiotic therapy, the establishment of long-term suppressive antibiotic therapy, or death from any cause within 1 year of the end of antibiotic therapy. We compared the treatment failure group with the treatment success group to determine risk factors for treatment failure.

resultsA total of 2881 patients underwent surgery during the study period, and 92 developed an SSI, corresponding to an SSI rate of 3.19%. Thirty-six percent of the patients with an SSI presented treatment failure. The median time to failure was 31 days. On multivariate analysis, diabetes mellitus was identified as a risk factor for treatment failure, whereas prolonged postoperative drainage for 4 to 5 days was a protective factor.

conclusionsThe number of failures was significant, and failure occurred mainly during the early phase. To decrease the risk of treatment failure, prolonged duration of postoperative drainage seems to be helpful. Additionally, as diabetes is a risk factor for treatment failure, good control of glycemia in these patients might impact their outcomes.

Indexed as

SpineSurgical Wound InfectionAnti-Bacterial AgentsHumansRetrospective StudiesRisk FactorsAnti-Bacterial AgentsAntibioticsDrainsSpine surgerySurgical site infection (SSI)Thoracolumbar instrumentation

Identifiers

PMID35128604
OpenAlexW4210319812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.